A Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment
Allan I. Levey, Deqiang Qiu, Liping Zhao, William T. Hu, Duc M. Duong, Lenora Higginbotham, Eric B. Dammer, Nicholas T. Seyfried, Thomas S. Wingo, Chadwick M. Hales, Malú Gámez Tansey, David Goldstein, Anees Abrol, Vince D. Calhoun, Felicia C. Goldstein, Ihab Hajjar, Anne M. Fagan, Doug Galasko, Steven D. Edland, John Hanfelt, James J. Lah, David Weinshenker
doi: https://doi.org/10.1101/2021.07.06.21260104
Allan I. Levey
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
2Department of NeurologyEmory University, Atlanta, Georgia, 30322, USA
Deqiang Qiu
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
7Radiology and Imaging Sciences Emory University, Atlanta, Georgia, 30322, USA
Liping Zhao
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
5Department of Biostatistics Emory University, Atlanta, Georgia, 30322, USA
William T. Hu
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
2Department of NeurologyEmory University, Atlanta, Georgia, 30322, USA
Duc M. Duong
4Department of Biochemistry Emory University, Atlanta, Georgia, 30322, USA
Lenora Higginbotham
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
Eric B. Dammer
4Department of Biochemistry Emory University, Atlanta, Georgia, 30322, USA
Nicholas T. Seyfried
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
4Department of Biochemistry Emory University, Atlanta, Georgia, 30322, USA
Thomas S. Wingo
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
2Department of NeurologyEmory University, Atlanta, Georgia, 30322, USA
6Department of Genetics Emory University, Atlanta, Georgia, 30322, USA
Chadwick M. Hales
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
2Department of NeurologyEmory University, Atlanta, Georgia, 30322, USA
Malú Gámez Tansey
3Department of Physiology Emory University, Atlanta, Georgia, 30322, USA
David Goldstein
8NINDS, NIH, Bethesda, MD, 20892, USA
Anees Abrol
9Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Georgia Institute of Technology, Emory University, Atlanta, GA, 30303, USA
Vince D. Calhoun
9Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Georgia Institute of Technology, Emory University, Atlanta, GA, 30303, USA
Felicia C. Goldstein
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
2Department of NeurologyEmory University, Atlanta, Georgia, 30322, USA
Ihab Hajjar
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
2Department of NeurologyEmory University, Atlanta, Georgia, 30322, USA
Anne M. Fagan
10Department of Neurology and Knight ADRC, Washington University, St. Louis, MO, 630130, USA
Doug Galasko
11Department of Neurosciences and ADRC, UCSD, San Diego, CA, 92093, USA
Steven D. Edland
11Department of Neurosciences and ADRC, UCSD, San Diego, CA, 92093, USA
John Hanfelt
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
5Department of Biostatistics Emory University, Atlanta, Georgia, 30322, USA
James J. Lah
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
2Department of NeurologyEmory University, Atlanta, Georgia, 30322, USA
David Weinshenker
1Goizueta Alzheimer’s Disease Research CenterEmory University, Atlanta, Georgia, 30322, USA
6Department of Genetics Emory University, Atlanta, Georgia, 30322, USA
Posted July 08, 2021.
A Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment
Allan I. Levey, Deqiang Qiu, Liping Zhao, William T. Hu, Duc M. Duong, Lenora Higginbotham, Eric B. Dammer, Nicholas T. Seyfried, Thomas S. Wingo, Chadwick M. Hales, Malú Gámez Tansey, David Goldstein, Anees Abrol, Vince D. Calhoun, Felicia C. Goldstein, Ihab Hajjar, Anne M. Fagan, Doug Galasko, Steven D. Edland, John Hanfelt, James J. Lah, David Weinshenker
medRxiv 2021.07.06.21260104; doi: https://doi.org/10.1101/2021.07.06.21260104
A Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment
Allan I. Levey, Deqiang Qiu, Liping Zhao, William T. Hu, Duc M. Duong, Lenora Higginbotham, Eric B. Dammer, Nicholas T. Seyfried, Thomas S. Wingo, Chadwick M. Hales, Malú Gámez Tansey, David Goldstein, Anees Abrol, Vince D. Calhoun, Felicia C. Goldstein, Ihab Hajjar, Anne M. Fagan, Doug Galasko, Steven D. Edland, John Hanfelt, James J. Lah, David Weinshenker
medRxiv 2021.07.06.21260104; doi: https://doi.org/10.1101/2021.07.06.21260104
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (679)
- Anesthesia (182)
- Cardiovascular Medicine (2685)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12318)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4161)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2699)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3935)
- Nursing (213)
- Nutrition (586)
- Oncology (2073)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (462)
- Public and Global Health (6583)
- Radiology and Imaging (1424)
- Respiratory Medicine (877)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)